A study to see whether homoeopathic medicine can reduce period pain and improve daily life in women who suffer from painful menstruation.

Effect of individualized homoeopathic treatment in 50 millesimal scale on pain intensity and quality of life in primary dysmenorrhea An open label, single arm interventional study - Nil

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2026/02/105079

Enrollment

Registered

2026-02-27

Start date

Unknown

Completion date

Unknown

Last updated

2026-03-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N944- Primary dysmenorrhea

Interventions

Intervention1: Individualized Homoeopathic medicine in 50 millesimal scale: Indicated individualized homoeopathic medicine in 50 millesimal scale will be prescribed after case taking . Dose and potenc

Eligibility

Inclusion criteria

Inclusion criteria: Diagnosed cases of primary dysmenorrhea clinically through symptoms pain in lower abdomen radiating to back and thigh, headache, nausea, vomiting etc. Age group between 13 to 35 years. WaLIDD score more than 5 moderate or above. Ability to understand either Bengali or Hindi or English. Participants who are willing to participate in the study and provide written informed consent. Participants aged 13 to 18 years, with written informed consent from a parent or legal guardian and assent from the participant.

Exclusion criteria

Exclusion criteria: Patients diagnosed with secondary dysmenorrhea. Cases suffering from uncontrolled systemic illness or life- threatening illness. Cases already undergoing homoeopathic treatment for any other chronic diseases. Substance abuse and/or dependency. Lactating women. Hormonal therapy within 3 months. Use of other medications or pain relivers during the study period

Design outcomes

Primary

Measure	Time frame
Change in pain intensity using WaLIDD scale in primary dysmenorrheaTimepoint: Baseline & 6 months	—

Secondary

Measure	Time frame
improvement in quality of life using EQ-5D-3L questionnaire and EQ VAS in primary dysmenorrheaTimepoint: Baseline & 6 months	—

Countries

India

Contacts

Public ContactDr Sankardas Chakrabarti

National institute of homoeopathy kolkata

drchakrabartisirmadam@gmail.com9421494947

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Apr 4, 2026